ITORIHENZ 150 TAB 10 S

About

ITORIHENZ 150 TAB 10 S is a higher strength formulation of a non-steroidal anti-inflammatory drug (NSAID), specifically a selective cyclooxygenase-2 (COX-2) inhibitor. It functions by targeting and blocking the COX-2 enzyme, which is primarily responsible for the synthesis of prostaglandins that mediate pain, inflammation, and fever. By selectively inhibiting COX-2, ITORIHENZ 150 effectively reduces inflammatory responses and provides significant pain relief, while aiming to minimize the impact on COX-1, an enzyme crucial for maintaining the protective lining of the stomach and normal blood clotting. This selective action is designed to offer potent anti-inflammatory and analgesic effects with a potentially lower incidence of gastrointestinal side effects compared to traditional non-selective NSAIDs. It is prescribed for the management of various acute and chronic inflammatory conditions requiring stronger symptomatic control.

Uses

• Relief of severe pain and inflammation in osteoarthritis.
• Management of advanced symptoms in rheumatoid arthritis.
• Treatment of acute exacerbations of ankylosing spondylitis.
• Alleviation of intense acute gouty arthritis pain.

Directions For Use

Take orally with or without food, as directed by your physician. Do not exceed the prescribed dose.

Benefits

• Potent pain and inflammation relief.
• Significant reduction in swelling.
• Improved functional mobility.
• Sustained therapeutic effect.
• Reduced risk of GI complications compared to non-selective NSAIDs.
• Effective for severe inflammatory conditions.

Side Effects

• Abdominal pain
• Nausea
• Diarrhea
• Indigestion
• Headache
• Dizziness
• Fluid retention
• High blood pressure
• Palpitations
• Fatigue
• Swelling of ankles/legs
• Heartburn

Safety Measures

• Alcohol - Concurrent use of alcohol with ITORIHENZ 150 may increase the risk of gastrointestinal irritation and bleeding. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - ITORIHENZ 150 is generally not recommended during pregnancy, especially in the third trimester, due to potential risks to the fetus, including premature closure of the ductus arteriosus. Consult a doctor.
• Breastfeeding - Small amounts of NSAIDs may pass into breast milk. Use during breastfeeding should be approached with caution and only if clearly necessary, under medical supervision.
• Liver - Use with caution in patients with mild to moderate liver impairment. ITORIHENZ 150 is contraindicated in severe liver disease due to increased risk of adverse effects.
• Kidney - Caution is advised in patients with pre-existing kidney disease as NSAIDs can impair renal function. Regular monitoring of kidney function may be necessary.
• Lung - Patients with asthma, especially aspirin-sensitive asthma, should use ITORIHENZ 150 with caution as it may exacerbate bronchospasm.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.